Home › Malattia epatica steatosica › Missouri › St. Louis
Studi clinici su Malattia epatica steatosica a St. Louis, MO
9 studi su Malattia epatica steatosica cercano partecipanti presso sedi a St. Louis e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
In reclutamentoFase 3
- 89bio Clinical Study Site, St Louis
- 89bio Clinical Study Site, St Louis
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
In reclutamentoFase 3
- 89bio Clinical Study Site, St Louis
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
In reclutamentoFase 3
- GSK Investigational Site, St Louis
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
In reclutamentoFase 3
- GSK Investigational Site, St Louis
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
In reclutamentoFase 2
- Washington University School of Medicine, St Louis
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
In reclutamentoFase 3
- Akero Clinical Study Site, St Louis
- Akero Clinical Study Site, St Louis
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
In reclutamentoFase 3
- GSK Investigational Site, St Louis
- GSK Investigational Site, St Louis
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
In reclutamentoFase 2
- Gateway GI Research, LLC, St Louis
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
In reclutamentoFase 3
- GSK Investigational Site, St Louis
Studi su Malattia epatica steatosica in altre città
- San Antonio, TX17 studi
- Miami, FL16 studi
- New York City, NY16 studi
- San Diego, CA14 studi
- Houston, TX13 studi
- Austin, TX13 studi
- Richmond, VA12 studi
- Tucson, AZ10 studi
- Chandler, AZ10 studi
- Hialeah, FL9 studi
- Dallas, TX9 studi
- Orlando, FL9 studi
Altri studi a St. Louis
- Cancro del polmone non a piccole cellule73 studi
- Cancro al seno64 studi
- Cancro metastatico54 studi
- Cancro colorettale50 studi
- Cancro (tutti i tipi)46 studi
- Cancro alla prostata46 studi
- Cancro ai polmoni39 studi
- Cancro ovarico38 studi
- Cancro pancreatico33 studi
- Cancro dell'endometrio29 studi
- Carcinoma a cellule squamose della testa e del collo28 studi
- Insufficienza cardiaca26 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.